Blog

  • Chest mobility, cough strength, muscle strength, physical activity, and quality of life in parkinson’s patients who had COVID-19 | BMC Pulmonary Medicine

    Chest mobility, cough strength, muscle strength, physical activity, and quality of life in parkinson’s patients who had COVID-19 | BMC Pulmonary Medicine

    Our study, whose primary research aim was to investigate impacts of a confirmed history of COVID-19 on muscle strength, chest mobility, physical activity, cough force, and QOL in Parkinson’s patients, yielded important results. Among Parkinson…

    Continue Reading

  • Hippo pathway suppression reprograms TNFα-primed glioblastoma extracellular vesicles transcripts cargo to drive mesenchymal stem/stromal cells vasculogenic mimicry | Cell Communication and Signaling

    Hippo pathway suppression reprograms TNFα-primed glioblastoma extracellular vesicles transcripts cargo to drive mesenchymal stem/stromal cells vasculogenic mimicry | Cell Communication and Signaling

  • Xue J, Zhang J, Zhu J. Unraveling molecular signatures and prognostic biomarkers in glioblastoma: a comprehensive study on treatment resistance and personalized strategies. Discov Oncol. 2024;15(1):743.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Seker-Polat F, Pinarbasi Degirmenci N, Solaroglu I, Bagci-Onder T. Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives. Cancers (Basel). 2022;14(2):443.

    CAS 
    PubMed 

    Google Scholar 

  • Skaga E, Kulesskiy E, Fayzullin A, Sandberg CJ, Potdar S, Kyttälä A, Langmoen IA, Laakso A, Gaál-Paavola E, Perola M, Wennerberg K, Vik-Mo EO. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma. BMC Cancer. 2019;19(1):628.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Dymova MA, Kuligina EV, Richter VA. Molecular mechanisms of drug resistance in glioblastoma. Int J Mol Sci. 2021;22(12):6385.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Narsinh KH, Perez E, Haddad AF, Young JS, Savastano L, Villanueva-Meyer JE, Winkler E, de Groot J. Strategies to improve drug delivery across the blood-brain barrier for glioblastoma. Curr Neurol Neurosci Rep. 2024;24(5):123–39.

    PubMed 
    PubMed Central 

    Google Scholar 

  • White J, White MPJ, Wickremesekera A, Peng L, Gray C. The tumour microenvironment, treatment resistance and recurrence in glioblastoma. J Transl Med. 2024;22(1):540.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Lv B, Wang Y, Ma D, Cheng W, Liu J, Yong T, Chen H, Wang C. Immunotherapy: reshape the tumor immune microenvironment. Front Immunol. 2022;13:844142.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Casati G, Giunti L, Iorio AL, Marturano A, Galli L, Sardi I. Hippo pathway in regulating drug resistance of glioblastoma. Int J Mol Sci. 2021;22(24):13431.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Masliantsev K, Karayan-Tapon L, Guichet PO. Hippo signaling pathway in gliomas. Cells. 2021;10(1):184.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kim MH, Kim J. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cell Mol Life Sci. 2017;74(8):1457–74.

    CAS 
    PubMed 

    Google Scholar 

  • Saadh MJ, Ahmed HH, Kareem RA, Bishoyi AK, Roopashree R, Shit D, Arya R, Sharma A, Khaitov K, Sameer HN, Yaseen A, Athab ZH, Adil M. Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications. Mol Biol Rep. 2025;52(1):267.

    CAS 
    PubMed 

    Google Scholar 

  • Yang D, Zhang N, Li M, Hong T, Meng W, Ouyang T. The Hippo signaling pathway: the trader of tumor microenvironment. Front Oncol. 2021;11:772134.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Azad T, Ghahremani M, Yang X. The role of YAP and TAZ in angiogenesis and vascular mimicry. Cells. 2019;8(5):407.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Roy ME, Elimam R, Zgheib A, Annabi B. A role for the Hippo/YAP1 pathway in the regulation of in vitro vasculogenic mimicry in glioblastoma cells. J Cell Mol Med. 2024;28(24):e70304.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20(1):7.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Roy ME, Veilleux C, Paquin A, Gagnon A, Annabi B. Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells. Anticancer Drugs. 2024;35(8):709–19.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • van Janse HJ, Taha Z. The Hippo pathway, immunity, and cancer: an update. J Cell Immunol. 2020;2(6):265–75.

    Google Scholar 

  • Oceandy D, Amanda B, Ashari FY, Faizah Z, Azis MA, Stafford N. The cross-talk between the TNF-α and RASSF-Hippo signalling pathways. Int J Mol Sci. 2019;20(9):2346.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lu J, Hu Z, Deng Y, Wu Q, Wu M, Song H. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. J Biol Chem. 2021;296:100400.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kabiraj P, Grund EM, Clarkson BDS, Johnson RK, LaFrance-Corey RG, Lucchinetti CF, Howe CL. Teriflunomide shifts the astrocytic bioenergetic profile from oxidative metabolism to Glycolysis and attenuates TNFα-induced inflammatory responses. Sci Rep. 2022;12(1):3049.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jena BC, Mandal M. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: an insight towards tumor-microenvironment interaction. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188488.

    CAS 
    PubMed 

    Google Scholar 

  • Semeradtova A, Liegertova M, Herma R, Capkova M, Brignole C, Del Zotto G. Extracellular vesicles in cancer´s communication: messages we can read and how to answer. Mol Cancer. 2025;24(1):86.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Franceschi S, Lessi F, Morelli M, Menicagli M, Aretini P, Gambacciani C, Pieri F, Grimod G, Trapanese MG, Valenti S, Paiar F, Di Stefano AL, Santonocito OS, Pasqualetti F, Mazzanti CM. Exploring extracellular vesicle surface protein markers produced by glioblastoma tumors: A characterization study using in vitro 3D patient-derived cultures. Cancers (Basel). 2024;16(22):3748.

    CAS 
    PubMed 

    Google Scholar 

  • Musatova OE, Rubtsov YP. Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells. Front Cell Dev Biol. 2023;11:1060000.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836–48.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gharib E, Veilleux V, Boudreau LH, Pichaud N, Robichaud GA. Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming. Front Immunol. 2023;14:1207631.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Veilleux V, Pichaud N, Boudreau LH, Robichaud GA. Mitochondria transfer by platelet-derived microparticles regulates breast cancer bioenergetic States and malignant features. Mol Cancer Res. 2024;22(3):268–81.

    CAS 
    PubMed 

    Google Scholar 

  • Gonzalez Suarez N, Fernandez-Marrero Y, Hébert MPA, Roy ME, Boudreau LH, Annabi B. EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. Cancer Cell Int. 2023;23(1):240.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(1):605–12.

    Google Scholar 

  • Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J, Béliveau R. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells. 2003;21(3):337–47.

    CAS 
    PubMed 

    Google Scholar 

  • Roy ME, Veilleux C, Annabi B. In vitro biomaterial priming of human mesenchymal stromal/stem cells: implication of the Src/JAK/STAT3 pathway in vasculogenic mimicry. Sci Rep. 2024;14(1):21444.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Heng BC, Zhang X, Aubel D, Bai Y, Li X, Wei Y, Fussenegger M, Deng X. An overview of signaling pathways regulating YAP/TAZ activity. Cell Mol Life Sci. 2021;78(2):497–512.

    CAS 
    PubMed 

    Google Scholar 

  • Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141(8):1614–26.

    CAS 
    PubMed 

    Google Scholar 

  • Boopathy GTK, Hong W. Role of Hippo pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol. 2019;7:49.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Saab S, Chang OS, Nagaoka K, Hung MC, Yamaguchi H. The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors. Am J Cancer Res. 2019;9(12):2719–29.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Yamaguchi H, Taouk GM. A potential role of YAP/TAZ in the interplay between metastasis and metabolic alterations. Front Oncol. 2020;10:928.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang W, Zhang M, Zhang TX, Liu JH, Hao MW, Yan X, Gao H, Lei QY, Cui J, Zhou X. YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis. JCI Insight. 2024;9(24):e178535.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Tang TT, Konradi AW, Feng Y, Peng X, Ma M, Li J, Yu FX, Guan KL, Post L. Small molecule inhibitors of TEAD auto-palmitoylation selectively inhibit proliferation and tumor growth of NF2-deficient mesothelioma. Mol Cancer Ther. 2021;20(6):986–98.

    CAS 
    PubMed 

    Google Scholar 

  • Paul S, Hagenbeek TJ, Tremblay J, Kameswaran V, Ong C, Liu C, Guarnaccia AD, Mondo JA, Hsu PL, Kljavin NM, Czech B, Smola J, Nguyen DAH, Lacap JA, Pham TH, Liang Y, Blake RA, Gerosa L, Grimmer M, Xie S, Daniel B, Yao X, Dey A. Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD Inhibition. Nat Commun. 2025;16(1):1743.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Chapeau EA, Sansregret L, Galli GG, Chène P, Wartmann M, Mourikis TP, Jaaks P, Baltschukat S, Barbosa IAM, Bauer D, Brachmann SM, Delaunay C, Estadieu C, Faris JE, Furet P, Harlfinger S, Hueber A, Jiménez E Núñez, Kodack DP, Mandon E, Martin T, Mesrouze Y, Romanet V, Scheufler C, Sellner H, Stamm C, Sterker D, Tordella L, Hofmann F, Soldermann N, Schmelzle T. Direct and selective Pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5(7):1102–20. Erratum in: Nat Cancer. 2024;5(7):1130.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Chène P. Direct Inhibition of the YAP: TEAD interaction: an unprecedented drug discovery challenge. ChemMedChem. 2024;19(19):e202400361.

    PubMed 

    Google Scholar 

  • Beck S, Hochreiter B, Schmid JA. Extracellular vesicles linking inflammation, cancer and thrombotic risks. Front Cell Dev Biol. 2022;10:859863.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu YJ, Wang C. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Commun Signal. 2023;21(1):77.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Xiang H, Bao C, Chen Q, Gao Q, Wang N, Gao Q, Mao L. Extracellular vesicles (EVs)’ journey in recipient cells: from recognition to cargo release. J Zhejiang Univ Sci B. 2024;25(8):633–55.

    PubMed 

    Google Scholar 

  • Annabi B, Naud E, Lee YT, Eliopoulos N, Galipeau J. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem. 2004;91(6):1146–58.

    CAS 
    PubMed 

    Google Scholar 

  • Bergers G. Bone marrow-derived cells in GBM neovascularization. In: Meir E, editor. CNS cancer. cancer.Drug discovery and development. Humana; 2009. https://doi.org/10.1007/978-1-60327-553-8_31.

  • Kim H, Son S, Ko Y, Lee JE, Kim S, Shin I. YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ERα. J Cell Sci. 2021;134(11):jcs256503.

    CAS 
    PubMed 

    Google Scholar 

  • Kumar R, Hong W. Hippo signaling at the hallmarks of cancer and drug resistance. Cells. 2024;13(7):564.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Schulz JA, Rodgers LT, Kryscio RJ, Hartz AMS, Bauer B. Characterization and comparison of human glioblastoma models. BMC Cancer. 2022;22(1):844.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A, Mokhtari K, Shahpasand K, Farahani N, Meybodi TE, Entezari M, Taheriazam A, Hushmandi K, Hashemi M. Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. Mol Cancer. 2025;24(1):58.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

Continue Reading

  • Scientists Unearth 200,000-Year-Old DNA—In a Place It Shouldn’t Have Survived

    Scientists Unearth 200,000-Year-Old DNA—In a Place It Shouldn’t Have Survived

    The study, led by the University of Tübingen and published in Nature Ecology & Evolution, marks a major advance in ancient DNA recovery. It challenges long-held assumptions that genetic material can only survive for millennia in frozen or…

    Continue Reading

  • Transient epileptic amnesia: temporal progression of partially treated disease—a case report | Journal of Medical Case Reports

    Transient epileptic amnesia: temporal progression of partially treated disease—a case report | Journal of Medical Case Reports

    This patient, with an unremarkable background history, had several episodes of transient, anterograde amnesia with preserved consciousness and language abilities before a formal diagnosis of TEA was made. The initial diagnosis was difficult and…

    Continue Reading

  • Table tennis has given me everything. It’s literally my life.

    Table tennis has given me everything. It’s literally my life.

    Hana Goda: Ambitions in Tunis

    Goda’s goals for the tournament are bold yet grounded.

    “I’m competing in teams, singles, doubles, and mixed doubles. Winning all four would be ideal, but I’m not putting too much pressure on myself. My main…

    Continue Reading

  • Immediate implant placement for single failed maxillary anterior teeth after trauma: a case-series study | BMC Oral Health

    Immediate implant placement for single failed maxillary anterior teeth after trauma: a case-series study | BMC Oral Health

    Patients and study design

    A review of the medical records of individuals who underwent immediate placement of dental implants following injuries to their teeth was performed. During the period spanning from January 2014 to December 2021, patients…

    Continue Reading

  • Maldon & Tiptree FC owner enjoying first FA Cup experience

    Maldon & Tiptree FC owner enjoying first FA Cup experience

    Elliot DeadyEssex and

    Paul GrunillBBC Sport, East

    BBC A smiling Barrie Drewitt-Barlow looking straight at the camera. He is sitting on a green seat in a football stadium in front of a blue wall with the logo of Maldon & Tiptree Football Club on it.BBC

    Barrie Drewitt-Barlow runs Maldon & Tiptree FC with his partner Scott Drewitt-Barlow

    The owner of non-league Maldon & Tiptree says he is loving his first FA Cup journey despite admitting he does…

    Continue Reading

  • WHO and the European Union launch collaboration to advance digitized health systems in sub-Saharan Africa

    WHO and the European Union launch collaboration to advance digitized health systems in sub-Saharan Africa

    The World Health Organization (WHO) and the European Union (EU) announced today a new agreement to support the digital transformation of health systems and wider adoption of WHO’s Global Digital Health Certification Network (GDHCN) in sub-Saharan Africa. This EU–WHO partnership will improve pandemic preparedness and accelerate progress towards better health and well-being for all.

    The agreement was announced at the World Health Summit 2025 by Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data; Dr Mohamed Yakub Janabi, WHO Regional Director for Africa; and Mr Martin Seychell, Deputy Director-General of the European Commission Directorate-General for International Partnerships.

    The GDHCN is a global system that enables countries to securely and reliably verify nationally approved digital health credentials across borders. The system builds on the European Union Digital COVID Certificate (EU DCC), which facilitated verification of vaccination, testing and recovery certification for international travelers connecting 76 countries and territories. However, only four countries from the WHO African Region—Benin, Cabo Verde, Seychelles and Togo—were able to join the EU DCC network.

    Since its transfer to the WHO in 2023, the GDHCN has shown strong potential to support the digitization of the International Certificate of Vaccination or Prophylaxis (ICVP), commonly known as the Yellow Card, in alignment with the updated International Health Regulations (IHR). Making the most of its potential could enhance global vaccination tracking, reduce fraud, and simplify international health requirements.

    Under the new joint agreement, which includes an €8 million EU grant spanning 2025 to 2028, WHO and the European Union will collaborate to bolster national efforts to advance the digital transformation of health systems in sub-Saharan Africa. WHO will provide technical and policy expertise, in collaboration with regional partners such as the Africa Centres for Disease Control and Prevention (Africa CDC).

    The EU investment is part of the Digital Health workstream of the Team Europe Initiative on the EU-AU Health Partnership, which brings together European and African stakeholders to build resilient digital health ecosystems across the continent, and aligned with the EU Global Gateway strategy.

    Empowering countries and people

    The GDHCN supports countries in building trusted, interoperable digital health systems that directly benefit people — providing secure, portable health records accessible wherever they travel, including during health emergencies. Personal health records are managed securely by each individual country or their health system. These records cannot be accessed by other parties, including WHO.

    The network is built on internationally recognized standards for privacy, data protection, and interoperability, and participation of countries is voluntary. The network fosters cross-border collaboration among countries and partners, strengthening health security today, while laying the foundation for more resilient, person-centered health systems for future generations.

    Continue Reading

  • Just a moment…

    Just a moment…

    Continue Reading

  • The association between retinal artery to vein ratio and fat distribution: a population-based cross-sectional study | BMC Ophthalmology

    The association between retinal artery to vein ratio and fat distribution: a population-based cross-sectional study | BMC Ophthalmology

  • Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9(6):653–60.

    CAS 
    PubMed 

    Google Scholar 

  • Hoon M, Okawa H, Della Santina L, Wong RO. Functional architecture of the retina: development…

    • Continue Reading